Replies to post #11189 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

PCinsurto, with Corti on deck and if Libigel were to rise, I could see it attracting someone like Brent Saunders of Allergan to lead the company. He just turned down a seat on the Board of the merged AbbVie/Allergan to seek other opportunities in the industry, that doesn't happen usually unless something is lined up. His base salary with Allergan was low by industry standard but did extremely well in overall compensation.

As for the M&A that could be why they tapped Patrick Walsh as interim CEO, freeing up Stephen Carey VP and CFO to work on M&A.

Just speculating at this point.